JangoBio
JangoBio therapies provide a complete hormone replacement solution for humans and animals. JangoBio utilizes regenerative stem-cell based precision medicine to restore circulating hormone balance required for optimal health and longevity. Headquartered near Madison, Wisconsin, JangoBio is an early-stage biotech company focused on developing new and novel methods to restore hormone balance in both humans and animals. Utilizing in-house advancements in regenerative stem-cell technology, JangoBio is developing a pipeline of first-in-class hormone restoration treatments. JangoBio recently completed a $2M seed round and is currently positioning itself for its next funding round and commercial revenue streams.
About JangoBio
Estimated Revenue
$1M-$10MEmployees
11-50Category
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
80NAICs Code
325Location
City
FitchburgState
WisconsinCountry
United StatesJangoBio
Find your buyer within JangoBio